New England Retina Consultants | Retina Research Institute
Status and phase
Conditions
Treatments
About
The goal of this clinical trial is to understand the safety of AXT107 injected suprachoroidally in participants with nAMD. The main question[s] it aims to answer are:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
15 participants in 3 patient groups
Loading...
Central trial contact
Amanda Boillino, RN
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal